Clinical Trial Update: A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the rotigotine transdermal patch (Neupro) in Parkinson's disease patients undergoing surgery; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2009-07-03